| Serial Number | 77504998 |
| Word Mark | NASALCARE |
| Filing Date | Sunday, June 22, 2008 |
| Status | 800 - REGISTERED AND RENEWED |
| Status Date | Tuesday, January 7, 2020 |
| Registration Number | 3688173 |
| Registration Date | Tuesday, September 29, 2009 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, January 20, 2009 |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Disclaimer with Predetermined Text | "NASALCARE" |
| Description of Mark | The mark consists of the wording "NASALCARE" with two curved lines representing air or vapor emanating from the "L". |
| Goods and Services | [ Analgesic and muscle relaxant pharmaceutical preparations; Anti-diabetic pharmaceuticals; ] Antibacterial pharmaceuticals; [ Antimicrobial preparations for inhibiting microbiological decomposition in food, beverages, animal feed and pharmaceuticals; ] [ Antimicrobial preservatives for cosmetics and pharmaceuticals; ] [ Astringents; Bismuth preparations for pharmaceutical purposes; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; ] Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; [ Drug delivery agents in the form of a coating for macromolecule agents that facilitate the delivery of a wide range of pharmaceuticals; Gelatin capsules sold empty for pharmaceuticals; ] Homeopathic pharmaceuticals for use in the treatment of allergy and respiratory tract infections; [ Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Inhalers filled with anti-infectives and anti-allergy pharmaceuticals; ] [ Injectable pharmaceuticals for treatment of anaphylactic reactions; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Ocular pharmaceuticals; Pharmaceutical anti-allergic preparations and substances; ] Pharmaceutical antitussive-cold preparations; [ Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; ] Pharmaceutical preparations and substances for the treatment of infectious diseases, [ blood disorders, ] pain, inflammation [, sepsis, alopecia, obesity and cognitive disorders ] ; [ Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; ] Pharmaceutical preparations for the prevention and treatment of [ ocular disorders or diseases, for the treatment of ] bacteria-based diseases, [ and for the treatment of diabetes, ] and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations [ and vaccines ] ; [ Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; ] Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; [ Pharmaceutical preparations for treating diabetes; ] Pharmaceutical preparations for use in chemotherapy; [ Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; ] Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; [ Pharmaceutical solutions used in dialysis; Pharmaceuticals for the treatment of erectile dysfunction; ] Pharmaceuticals, namely, anti-infectives; [ Pharmaceuticals, namely, antihelmintics; ] [ Pharmaceuticals, namely, inducers of erections; Pharmaceuticals, namely, lipid lowering agents; Plant extracts for medical, veterinary and pharmaceutical purposes; ] [ Potassium preparations for pharmaceutical purposes; ] [ Radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use; Synthetic peptides for pharmaceutical purposes; Unit dose capsules sold empty for pharmaceutical use; Vitamin and mineral preparations for use as ingredients in the food and pharmaceutical industry; Yeast or yeast extracts for medical, veterinary or pharmaceutical purposes ] |
| Pseudo Mark | NASAL CARE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, June 25, 2008 |
| Primary Code | 005 |
| First Use Anywhere Date | Tuesday, January 2, 2007 |
| First Use In Commerce Date | Tuesday, January 2, 2007 |
| Party Name | TechWorld Corporation, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Newport, DE 19804 |
| Party Name | TechWorld Corporation, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Dowingintown, PA 19335 |
| Party Name | TechWorld Corporation, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Dowingintown, PA 19335 |
| Event Date | Event Description |
| Tuesday, January 7, 2020 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED |
| Tuesday, January 7, 2020 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) |
| Tuesday, January 7, 2020 | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
| Monday, January 6, 2020 | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED |
| Friday, January 3, 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Sunday, July 7, 2019 | POST REGISTRATION ACTION MAILED - SEC. 8 & 9 |
| Sunday, July 7, 2019 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Friday, June 21, 2019 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, June 21, 2019 | TEAS SECTION 8 & 9 RECEIVED |
| Saturday, September 29, 2018 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
| Wednesday, October 12, 2016 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
| Wednesday, October 12, 2016 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| Wednesday, September 28, 2016 | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED |
| Tuesday, September 27, 2016 | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED |
| Monday, June 6, 2016 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, May 27, 2016 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, April 8, 2016 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Sunday, April 3, 2016 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, March 28, 2016 | POST REGISTRATION ACTION MAILED - SEC. 8 & 15 |
| Friday, March 25, 2016 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, March 25, 2016 | TEAS SECTION 8 & 15 RECEIVED |
| Saturday, December 13, 2014 | POST REGISTRATION ACTION MAILED - SEC. 8 & 15 |
| Monday, November 24, 2014 | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED |
| Monday, October 6, 2014 | POST REGISTRATION ACTION MAILED - SEC. 8 & 15 |
| Monday, October 6, 2014 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Tuesday, September 30, 2014 | TEAS SECTION 8 & 15 RECEIVED |
| Tuesday, September 30, 2014 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, September 29, 2009 | REGISTERED-PRINCIPAL REGISTER |
| Wednesday, August 26, 2009 | TTAB RELEASE CASE TO TRADEMARKS |
| Wednesday, August 26, 2009 | OPPOSITION TERMINATED NO. 999999 |
| Wednesday, August 26, 2009 | OPPOSITION DISMISSED NO. 999999 |
| Thursday, March 12, 2009 | OPPOSITION INSTITUTED NO. 999999 |
| Wednesday, February 4, 2009 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Tuesday, January 20, 2009 | PUBLISHED FOR OPPOSITION |
| Wednesday, December 31, 2008 | NOTICE OF PUBLICATION |
| Tuesday, December 16, 2008 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Tuesday, December 16, 2008 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, December 16, 2008 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, December 16, 2008 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, December 16, 2008 | ASSIGNED TO LIE |
| Monday, December 1, 2008 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, December 1, 2008 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, October 3, 2008 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, October 3, 2008 | NON-FINAL ACTION E-MAILED |
| Friday, October 3, 2008 | NON-FINAL ACTION WRITTEN |
| Friday, September 26, 2008 | ASSIGNED TO EXAMINER |
| Thursday, June 26, 2008 | NOTICE OF DESIGN SEARCH CODE MAILED |
| Wednesday, June 25, 2008 | NEW APPLICATION ENTERED IN TRAM |